The nano-revolution in the diagnosis and treatment of endometriosis

Nanoscale · 2023 · vol. 15(43) , pp. 17313–17325 · doi:10.1039/d3nr03527a · PMID:37874212
review OA: hybrid CC-BY-NC-4.0
AI-generated summary by claude@2026-06, 2026-06-08

This review highlights nanomedicine's promising applications in diagnosing and treating endometriosis, focusing on theranostics and phototherapy combinations.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-08 · read from full text

This paper is a brief review of recent nanomedicine advances aimed at improving the diagnosis and treatment of endometriosis, emphasizing non-invasive approaches and new patient follow-up strategies in response to the disease’s high prevalence and burden. It reports that findings in the literature show potential for nanotechnology in both diagnostic and therapeutic phases, with special focus on theranostic nanoproducts and the combination of phototherapy with nanotechnology as emerging modalities. The paper also outlines parameters to consider when designing research for these nano-based approaches, but it does so as a review, so it does not present new original experiments or primary patient outcome data. This paper is centrally about endometriosis — it reviews nano-revolution concepts, including nanodiagnostics, nanotherapies, and theranostic phototherapy-nanotechnology strategies for endometriosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Endometriosis is a painful gynecological disease with a high prevalence, affecting millions of women worldwide. Innovative, non-invasive treatments, and new patient follow-up strategies are needed to deal with the harmful social and economic effects. In this scenario, considering the recent, very promising results already reported in the literature, a commitment to new research in the field of nanomedicine is urgently needed. Study findings clearly show the potential of this approach in both the diagnostic and therapeutic phases of endometriosis. Here, we offer a brief review of the recent exciting and effective applications of nanomedicine in both the diagnosis and therapy of endometriosis. Special emphasis will be placed on the emerging theranostic application of nanoproducts, and the combination of phototherapy and nanotechnology as new therapeutic modalities for endometriosis. The review will also provide interested readers with a guide to the selection process and parameters to consider when designing research into this type of approach.
Full text 1,207 characters · extracted from oa-doi-fallback · click to expand
The nano-revolution in the diagnosis and treatment of endometriosis Abstract Endometriosis is a painful gynecological disease with a high prevalence, affecting millions of women worldwide. Innovative, non-invasive treatments, and new patient follow-up strategies are needed to deal with the harmful social and economic effects. In this scenario, considering the recent, very promising results already reported in the literature, a commitment to new research in the field of nanomedicine is urgently needed. Study findings clearly show the potential of this approach in both the diagnostic and therapeutic phases of endometriosis. Here, we offer a brief review of the recent exciting and effective applications of nanomedicine in both the diagnosis and therapy of endometriosis. Special emphasis will be placed on the emerging theranostic application of nanoproducts, and the combination of phototherapy and nanotechnology as new therapeutic modalities for endometriosis. The review will also provide interested readers with a guide to the selection process and parameters to consider when designing research into this type of approach. - This article is part of the themed collection: Recent Review Articles

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Female Female Female Female Female Female Humans Humans Humans Humans Humans Humans

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-06-14T06:08:20.186862+00:00
pubmed
last seen: 2026-06-14T06:06:50.391199+00:00
unpaywall
last seen: 2026-05-14T19:30:52.867331+00:00
License: CC-BY-NC-4.0 · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine